Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.

By E. Louis, J. Mary, G. Vernier‐Massouille, J. Grimaud, Y. Bouhnik, D. Laharie, J. Dupas, H. Pillant, L. Picon, M. Veyrac and 9 more. Gastroenterology, 2012

623 citations recorded by the source corpus.

Subfields: Genetics, Immunology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/5f6334c9bc333640e6c7919f2b9c400bfa7612fb